Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29004281 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL17135371 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL1773307 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL3701351 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL17135372 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL17352702 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL387640 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL1245200 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL182183 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL387225 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118202109-A | Composition containing treatment agent 1 for synthetic fibers, method for producing diluent for treatment agent for synthetic fibers, method for treating synthetic fibers, method for producing synthetic fibers, and method for producing short fibers | 竹本油脂株式会社 | 2024-06-14 | — | — | CN | disclosed |
| EP-4368771-A1 | TREATMENT AGENT FOR SHORT FIBERS, AQUEOUS SOLUTION FOR TREATMENT AGENT FOR SHORT FIBERS, TREATMENT METHOD FOR SHORT FIBERS, PRODUCTION METHOD FOR SHORT FIBERS, AND SHORT FIBERS | Takemoto Yushi Kabushiki Kaisha (JP) | 2024-05-15 | — | — | EP | disclosed |
| EP-4368770-A1 | TREATMENT AGENT FOR FIBERS, FIRST TREATMENT AGENT FOR FIBERS, SECOND TREATMENT AGENT FOR FIBERS, COMPOSITION CONTAINING FIRST TREATMENT AGENT FOR FIBERS, DILUENT FOR TREATMENT AGENT FOR FIBERS, TREATMENT METHOD FOR FIBERS, AND FIBERS | Takemoto Yushi Kabushiki Kaisha (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-115997055-B | Treatment agent 1 for synthetic fibers, treatment agent for synthetic fibers, method for preparing aqueous liquid, method for treating synthetic fibers, staple fibers, spun yarns, and nonwoven fabric | 竹本油脂株式会社 | 2024-04-12 | — | — | CN | disclosed |
| WO-2024058150-A1 | TREATMENT AGENT FOR POLYESTER-BASED SYNTHETIC FIBERS, COMPOSITION CONTAINING TREATMENT AGENT FOR POLYESTER-BASED SYNTHETIC FIBERS, FIRST TREATMENT AGENT FOR POLYESTER-BASED SYNTHETIC FIBERS, COMPOSITION CONTAINING FIRST TREATMENT AGENT FOR POLYESTER-BASED SYNTHETIC FIBERS, SECOND TREATMENT AGENT FOR POLYESTER-BASED SYNTHETIC FIBERS, COMPOSITION CONTAINING SECOND TREATMENT AGENT FOR POLYESTER-BASED SYNTHETIC FIBERS, DILUTED SOLUTION OF TREATMENT AGENT FOR POLYESTER-BASED SYNTHETIC FIBERS, METHOD FOR TREATING POLYESTER-BASED SYNTHETIC FIBER, AND POLYESTER-BASED SYNTHETIC FIBER | 竹本油脂株式会社 | 2024-03-21 | — | — | WO | disclosed |
| CN-117597485-A | Fiber treating agent, first fiber treating agent, second fiber treating agent, composition containing first fiber treating agent, dilution of fiber treating agent, method for treating fiber, and fiber | 竹本油脂株式会社 | 2024-02-23 | — | — | CN | disclosed |
| CN-117597486-A | Short fiber treating agent, aqueous liquid of short fiber treating agent, method for treating short fiber, method for producing short fiber, and short fiber | 竹本油脂株式会社 | 2024-02-23 | — | — | CN | disclosed |
| WO-2024014310-A1 | COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND | L'OREAL (FR) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024014311-A1 | COSMETIC COMPOSITION COMPRISING SELECTED OIL AND DIOL | L'OREAL (FR) | 2024-01-18 | — | — | WO | disclosed |
| US-20230366143-A1 | SYNTHETIC FIBER FIRST PROCESSING AGENT, SYNTHETIC FIBER PROCESSING AGENT, AQUEOUS SOLUTION PREPARATION METHOD, SYNTHETIC FIBER PROCESSING METHOD, SYNTHETIC FIBERS, SHORT FIBERS, SPUN YARD AND NON-WOVEN FABRIC | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 2023-11-16 | — | — | US | disclosed |
| US-20070142335-A1 | Amino alcohol compounds or phosphonic acid derivatives thereof | SANKYO COMPANY, LIMITED (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1300405-B1 | AMINO ALCOHOL DERIVATIVES | SANKYO CO (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-7199150-B2 | Amino alcohol compounds | SANKYO COMPANY, LIMITED (JP) | 2007-04-03 | — | — | US | disclosed |
| US-6964976-B2 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2005-11-15 | — | — | US | disclosed |
| US-20050043386-A1 | Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these | SANKYO COMPANY, LIMITED (JP) | 2005-02-24 | — | — | US | disclosed |
| EP-1471054-A1 | AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE | Sankyo Company, Limited (JP) | 2004-10-27 | — | — | EP | disclosed |
| US-20040132784-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-08 | — | — | US | disclosed |
| US-6723745-B2 | PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL | SANKYO COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20030236297-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-12-25 | — | — | US | disclosed |
| EP-1300405-A1 | AMINO ALCOHOL DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236297-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | LMNA 3703/4885HIF1A 2134/4885EPAS1 2644/4885 |
| US-20050043386-A1 | Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these | PHOSPHO1, CD4, FCGRT | LMNA 4143/4885HIF1A 1588/4885EPAS1 647/4885 |
| US-20040132784-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | LMNA 3703/4885HIF1A 2134/4885EPAS1 2644/4885 |
| US-20070142335-A1 | Amino alcohol compounds or phosphonic acid derivatives thereof | HRH3, C3AR1, HRH4 | LMNA 2699/4885HIF1A 1862/4885EPAS1 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.